Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Nov;60(7):789-98.
doi: 10.1007/s00038-015-0708-5. Epub 2015 Aug 23.

Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis

Affiliations
Meta-Analysis

Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis

Monica Alonso et al. Int J Public Health. 2015 Nov.

Abstract

Objectives: Summarize hepatitis C virus (HCV) prevalence in injecting (IDU) and non-injecting drug users (NIDU), men who have sex with men (MSM), sex workers, and prison inmates in Latin America and the Caribbean (LAC).

Methods: Systematic review on HCV prevalence in sub-populations in LAC. Databases searched from 1-1-2000 to 10-30-2013.

Inclusion criteria: prevalence studies in sub-populations in LAC. HCV-antibody was marker for prevalence of current/past HCV infection and HCV-RNA for prevalence of HCV current infection.

Results: IDU HCV current/past infection presented highest prevalence, from 1.7 % in Colombia to over 95 % in Ciudad Juarez and Tijuana, Mexico and pooled regional anti-HCV prevalence was 49 % (CI 95 % 22.6-76.3 %). NIDU, MSM and sex workers anti-HCV prevalence was below 10 %, and pooled regional prevalence of 4 % (CI 95 % 2.6-4.5 %), 3 % (CI 95 % 1.7-4.5 %) and 2 % (CI 95 % 1.0-3.4 %), respectively. Prison inmates presented higher values, but prevalence decreased over the 15-year time span (p < 0.001). Current HCV infection from three countries showed prevalence under 10 % in prison inmates and 1-46 % among drug users.

Conclusions: Disease burden is high and surveillance, prevention and treatment should target these groups in LAC.

Keywords: Caribbean; Drug users; Hepatitis C; Latin America; Men who have sex with men; Prisoners.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of the study selection procedure for the review on prevalence of current and/or past Hepatitis C infection in Latin America and the Caribbean from 2000 to 2013
Fig. 2
Fig. 2
Forest plot for hepatitis C infection prevalence in Latin America and the Caribbean from 2000 to 2013. DU drug users, IDU injecting drug users, NI DU non-injecting drug users, MSM men who have sex with men
Fig. 3
Fig. 3
Forest plot for current Hepatitis C infection prevalence Hepatitis C infection in Latin America and the Caribbean from 2000 to 2013. DU drug users, IDU injecting drug users, NIDU non-injecting drug users

References

    1. Aceijas C, Rhodes R. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–358. doi: 10.1016/j.drugpo.2007.04.004. - DOI - PubMed
    1. Alvarado-Esquivel C, Sablon E, Martinez-Garcia S, et al. Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol Infect. 2005;133(4):679–685. doi: 10.1017/S0950268805003961. - DOI - PMC - PubMed
    1. Barros LA, Pessoni GC, Teles SA, et al. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goias, Central Brazil. Rev Soc Bras Med Trop. 2013;46(1):24–29. doi: 10.1590/0037-868216972013. - DOI - PubMed
    1. Bastos FI, Lowndes CM, Castello-Branco LR, et al. Sexual behaviour and infection rates for HIV, blood-borne and sexually transmitted infections among patients attending drug treatment centres in Rio de Janeiro, Brazil. Int J STD AIDS. 2000;11(6):383–392. doi: 10.1258/0956462001916100. - DOI - PubMed
    1. Bautista Amorocho H, Jaimes Moreno BZ, Hincapié López ML. Ausencia de infección por virus de la hepatitis C en usuarios de drogas ilícitas en la ciudad de Bucaramanga, Colombia’s Absence of hepatitis C infection among illegal drug users in Bucaramanga, Colombia. Rev Colomb Gastroenterol. 2011;26(1):15–20.